Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05810220 · ClinicalTrials.gov registry record · NA

Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants

A NA study of Deafness, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT05810220 is a NA study of Deafness that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 200 participants, below the 599-participant average among 11 other Deafness trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05810220, a NA study of Deafness, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This is a basic investigational research study conducted with hearing impaired adults and children who use cochlear implant or auditory brainstem implant (ABI) devices. The study will evaluate different aspects of hearing and auditory processing in the users of implantable auditory devices.

Conditions Studied

Interventions

  • DEVICE Electrode-Neural Interface

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2018-12-02
Est. Completion 2026-12
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT05810220

The ClinicalTrials.gov registry entry for NCT05810220 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 599-participant average among 11 other Deafness trials with a reported enrollment target (67% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Deafness appearing as the primary indexed condition, and to 1 intervention - of which Electrode-Neural Interface is the first listed.

NCT05810220 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05810220 about?

NCT05810220 is a clinical study titled "Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants". This is a basic investigational research study conducted with hearing impaired adults and children who use cochlear implant or auditory brainstem implant (ABI) devices. The study will evaluate different aspects of hearing and auditory processing in the users of implantable auditory devices.

What is the current status of trial NCT05810220?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2018-12-02. Estimated completion is 2026-12.

What conditions does trial NCT05810220 study?

This clinical trial studies the following conditions: Deafness.

What interventions are being tested in trial NCT05810220?

The interventions under investigation include: Electrode-Neural Interface (DEVICE).

Who is sponsoring clinical trial NCT05810220?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05810220 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Deafness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.